Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Get LinkedIn with JNM! Join your peers and follow us at “The Journal of Nuclear Medicine – JNM”

  • CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
  • 18F-4FMFES and 18F-FDG PET/CT in Estrogen Receptor–Positive Endometrial Carcinomas: Preliminary Report
  • Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
  • JNM Impact Factor 10.057
    The Journal of Nuclear Medicine Impact Factor Surges More than 27%, ranking third among all medical imaging journals worldwide.
  • 1
  • 2
  • 3
  • 4

Published Ahead of Print

  • You have access
    Invited Perspective, Outcome of patients with PSMA-PET/CT screen failure by VISION criteria and treated with 177Lu-PSMA therapy: a multicenter retrospective analysis
    Oliver Sartor
    Journal of Nuclear Medicine May 26, 2022, jnumed.122.264128; DOI: https://doi.org/10.2967/jnumed.122.264128
  • You have access
    Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single Domain Antibody Fragment
    Yutian Feng, Rebecca Meshaw, Xiao-guang Zhao, Stephen A. Jannetti, Ganesan Vaidyanathan and Michael R. Zalutsky
    Journal of Nuclear Medicine May 26, 2022, jnumed.122.264071; DOI: https://doi.org/10.2967/jnumed.122.264071
  • You have access
    Choice is good at times: the emergence of [64Cu]Cu-DOTATATE based somatostatin receptor imaging in the era of [68Ga]Ga-DOTATATE
    Abhishek Jha, Mayank Patel, Jorge A. Carrasquillo, Clara C. Chen, Corina C. Millo, Roberto Maass-Moreno, Alexander Ling, Frank I Lin, Ronald M. Lechan, Thomas A. Hope, David A. Taieb, Ali Cahid Civelek and Karel Pacak
    Journal of Nuclear Medicine May 26, 2022, jnumed.122.264183; DOI: https://doi.org/10.2967/jnumed.122.264183
  • You have access
    Repetitive early FAPI-PET acquisition comparing FAPI-02, FAPI-46 and FAPI-74: methodological and diagnostic implications for malignant, inflammatory and degenerative lesions
    Frederik M. Glatting, Jorge Hoppner, Dawn P. Liew, Antonia van Genabith, Anna-Maria Spektor, Levin Steinbach, Alexander Hubert, Clemens Kratochwil, Frederik L. Giesel, Katharina Dendl, Hendrik Rathke, Hans-Ulrich Kauczor, Peter E. Huber, Uwe A. Haberkorn and Manuel Röhrich
    Journal of Nuclear Medicine May 26, 2022, jnumed.122.264069; DOI: https://doi.org/10.2967/jnumed.122.264069
  • You have access
    Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE guidelines)
    Abhinav K. Jha, Tyler J. Bradshaw, Irène Buvat, Mathieu Hatt, Prabhat KC, Chi Liu, Nancy F. Obuchowski, Babak Saboury, Piotr J. Slomka, John J. Sunderland, Richard L. Wahl, Zitong Yu, Sven Zuehlsdorff, Arman Rahmim and Ronald Boellaard
    Journal of Nuclear Medicine May 26, 2022, jnumed.121.263239; DOI: https://doi.org/10.2967/jnumed.121.263239
  • You have access
    A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake
    Andrea Galbiati, Aureliano Zana, Matilde Bocci, Jacopo Millul, Abdullah Elsayed, Jacqueline Mock, Dario Neri and Samuele Cazzamalli
    Journal of Nuclear Medicine May 19, 2022, jnumed.122.264036; DOI: https://doi.org/10.2967/jnumed.122.264036
View more published ahead of print articles

Featured Articles

  • Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 1: Technical...
    April 28, 2022
  • Signaling Pathways That Drive 18F-FDG Accumulation in Cancer
    April 28, 2022
  • Total-Body PET: Will It Change Science and Practice?
    April 28, 2022
  • A Guideline for Clinicians Performing Clinical Studies with Fluorescence Imaging
    April 28, 2022
  • Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
    April 28, 2022
  • 18F-4FMFES and 18F-FDG PET/CT in Estrogen Receptor–Positive Endometrial...
    April 28, 2022
  • CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-...
    April 28, 2022

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.

Current issue

Journal of Nuclear Medicine: 63 (5)
Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
  • Most Cited
  • Most Read
Loading
  • Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
  • Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
  • Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
More...
Back to top
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire